SEL
Secara umum 4 gol.sel:
1.sel epitel,
2.sel jaringan penghubung,
3.sel jar.otot,
4.sel jar.saraf.
TUBUH MANUSIA
Sel-sel
Jaringan
Organ-organ
Sistem-sistem
Tubuh Manuasia
Patologi 4 aspek :
-etiologi,
-mekanisme (patogenesis),
-perubahan sel/jar.,
-akibat/perubahan morfologi
Sel-sel hidup dan stabil, jejas mk:
1, beradaptasi, 2,jejas reversibel,3.jejas
ireversibel,
Penyebab jejas
:hipoksi,fisika,kimia,infeksi,obat,imumunologi,
genetik&ketidak seimbangan gizi.
JENIS EKSUDAT = BENTUK RADANG
JEJAS
JARINGAN SEL
RESOLUSI EKSUDAT
ASAL JARINGAN
EKSUDAT DIORGANISER
SEL
SEL STABIL SEL LABIL PERMANEN
PEMULIHAN JARINGAN
KE PARUT KERANGKA UTUH KERANGKA RUSAK
STRUKTUR
NORMAL
REGENERASI JARINGAN PARUT JARINGAN
ASPEK BERUBAHAN Fungsi
SEL/STRUKTUR SEL :
- retrogresif,-progresif,-adaptasi.
Contoh : displasia, nekrosis, apoptosis,atrofi,
hipertrofi, hiperplasia dan metaplasia.
AKIBAT JEJAS SEL ADAPTIF, REVERSIBLE,
IREVERSIBLE
Sel
Jejas ringan, kurang Normal
bermakna Jejas hebat letal
Jejas ringan-sedang,
sub-letal
Peningkatan
Kebutuhan Kerusakan Sel Kerusakan Sel
Fungsional REVERSIBLE IREVERSIBLE
Jejas persisten : tahapan Peningkatan :
kerusakan kronik intensitas dan periode
ADAPTASI
(tidak ada perubahan kimia)
HIPERTROFI HIPERPLASIA
Akumulasi
ATROFI METAPLASIA (Storage,
DISPLASIA
Degeneration,
Tak terkontrol Infiltration)
ANAPLASI
“transformasi”
Jejas ringan cepat
berlalu
NEOPLASMA
X Jejas reda (hilang)
Kematian Sel
Sel kembali (NEKROSIS)
Normal
Spectrum of CIN
HIPERPLASI
HIPERTROFI
ATROFI
METAPLASI
03/19/21 cell-injury-pafkugm-tums 12
NEKROSIS-APOPTOSIS
HIPERPLASIA
03/19/21 cell-injury-pafkugm-tums 14
Aktivitas Telomerase
03/19/21 cell-injury-pafkugm-tums 15
Kapasitas proliferatif sel
(hipotesis telomer-telomerase)
03/19/21 cell-injury-pafkugm-tums 16
Hiperplasi Kompensatorik
03/19/21 cell-injury-pafkugm-tums 17
Hipeplasia of liver cells post partial hepatectomy
03/19/21 cell-injury-pafkugm-tums 18
Hipertrofi
03/19/21 cell-injury-pafkugm-tums 19
Hipertrofi ventrikel kiri konsentrik
Barret’s metaplasia
03/19/21 cell-injury-pafkugm-tums 21
SQUAMOUS METAPLASIA
19/03/21 PAFKUGM 22
Lintas diferensiasi stem cell
03/19/21 cell-injury-pafkugm-tums 23
Intracellular accumulation
03/19/21 cell-injury-pafkugm-tums 24
Fatty Change (liver)
03/19/21 cell-injury-pafkugm-tums 25
Fatty Liver
03/19/21 cell-injury-pafkugm-tums 26
Fatty Change (cholesterolosis)
03/19/21 cell-injury-pafkugm-tums 27
Proteinopathy / protein aggregation diseases
03/19/21 cell-injury-pafkugm-tums 28
Lipofuchsin pigment in cardiac myocyte
03/19/21 cell-injury-pafkugm-tums 29
Hemosiderin granules in liver cells
03/19/21 cell-injury-pafkugm-tums 30
Model Kalsifikasi
03/19/21 cell-injury-pafkugm-tums 31
Kalsifikasi
03/19/21 cell-injury-pafkugm-tums 32
Phenotypic change in hypertrophy
03/19/21 cell-injury-pafkugm-tums 33
ATROFI
35
METAPLASIA
03/19/21 cell-injury-pafkugm-tums 36
METAPLASIA
Barret’s metaplasia
03/19/21 cell-injury-pafkugm-tums 37
Lintas diferensiasi stem cell
03/19/21 cell-injury-pafkugm-tums 38
Intracellular accumulation
03/19/21 cell-injury-pafkugm-tums 39
Fatty Change (liver)
03/19/21 cell-injury-pafkugm-tums 40
Fatty Liver
03/19/21 cell-injury-pafkugm-tums 41
Fatty Change (cholesterolosis)
03/19/21 cell-injury-pafkugm-tums 42
Proteinopathy / protein aggregation diseases
03/19/21 cell-injury-pafkugm-tums 43
Lipofuchsin pigment in cardiac myocyte
03/19/21 cell-injury-pafkugm-tums 44
Hemosiderin granules in liver cells
03/19/21 cell-injury-pafkugm-tums 45
Model Kalsifikasi
03/19/21 cell-injury-pafkugm-tums 46
Kalsifikasi
03/19/21 cell-injury-pafkugm-tums 47